Company Filing History:
Years Active: 2010
Title: Graham M T Cheetham: Innovator in Molecular Structures
Introduction
Graham M T Cheetham is a notable inventor based in Abingdon, GB. He has made significant contributions to the field of molecular biology, particularly in the study of polo-like kinase 3 (PLK3). His work has implications for understanding protein structures and developing potential therapeutic compounds.
Latest Patents
Cheetham holds a patent for the "Crystal structure of polo-like kinase 3 (PLK3) and binding pockets thereof." This invention relates to molecules or molecular complexes that comprise binding pockets of PLK3 or its structural homologues. The patent details crystallizable compositions and crystals that include PLK3. Additionally, it describes a data storage medium encoded with the structural coordinates of these molecules, which can be utilized to generate three-dimensional representations. The invention also outlines methods for using these coordinates to identify and design compounds that can inhibit PLK3 or its homologues.
Career Highlights
Graham M T Cheetham is associated with Vertex Pharmaceuticals, Inc., where he continues to advance research in molecular structures. His work is pivotal in the development of new therapeutic strategies targeting PLK3, which is crucial for various cellular processes.
Collaborations
Cheetham has collaborated with notable colleagues, including Kieron Brown and Suzanne B Renwick. Their combined expertise enhances the research efforts at Vertex Pharmaceuticals, Inc.
Conclusion
Graham M T Cheetham's innovative work in the field of molecular biology, particularly regarding PLK3, showcases his commitment to advancing scientific knowledge and therapeutic development. His contributions are vital for future research and applications in this area.